跳至主要内容
临床试验/CTRI/2011/12/002182
CTRI/2011/12/002182已完成3 期

Role of gabapentin as adjuvant analgesic with opioids for neuropathic cancer pain when combined with low dose amitriptyline in cancer subjects of Tripura, a North Eastern state of India. - Nil

Indian Council of Medical Research0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a.Age 18 years to 80 years
  • b.Cancer Patients with neuropathic pain not controlled with opioid analgesics.
  • c.Worst pain intensity >= 5 on a NRS from 0 â?? 10, in the 24 hour period to study entry.
  • d.Stable dose of regularly scheduled systemic opioid therapy (Morphine >= 60 mg / 24 hour without sufficient analgesia for at least 24 hour.
  • e.Life expectancy >= 30 days.
  • f.Karnofsky performance status (KPS) >= 40.

排除标准

  • a.Serum creatinine 2 times the upper limit of normal.
  • b.Serum liver enzyme 5 times the upper limit of normal.
  • c.Serum sodium 130 m Eq.
  • d.Unable to take medication orally.
  • e.Pregnant and lactating subjects.
  • f.Other organ dysfunction.
  • g.Chemotherapy from 3 days before screening.
  • h.Radiotherapy to the pain producing lesion from 15 days before screening.
  • i.Patients unable to communicate fluency in Bengali Hindi or English.
  • j.Patients with history of epilepsy or use of anti epileptic drugs or neuropathic analgesics other than opioids.

研究者

相似试验